The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease

Feng Ying C. Lin, Ruth A. Brenner, Yvette R. Johnson, Parvin H. Azimi, Joseph B. Philips, Joan A. Regan, Penny Clark, Leonard E. Weisman, George Rhoads, Fanhui Kong, John D. Clemens

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to evaluate the effectiveness of a risk-based intrapartum antibiotic prophylaxis strategy for the prevention of early-onset neonatal group B streptococcal disease. STUDY DESIGN: Cases and controls were selected from infants born to women with one or more risk factors: preterm labor or rupture of membranes, prolonged rupture of membranes (>18 hours), fever during labor, or previous child with group B streptococcal disease. Cases were matched with controls by birth hospital and gestational age. Data abstracted from medical records were analyzed to estimate the effectiveness of intrapartum antibiotic prophylaxis. RESULTS: We analyzed data from 109 cases and 207 controls. Nineteen (17%) case versus 69 (33%) control mothers received an acceptable regimen of intrapartum antibiotic prophylaxis. In adjusted analyses, the effectiveness of intrapartum antibiotic prophylaxis was 86% (95% confidence interval, 66%-94%). When the first dose of antibiotics was given ≥2 hours before delivery, the effectiveness increased to 89% (95% confidence interval, 70%-96%); when it was given within 2 hours of delivery, the effectiveness was 71% (95% confidence interval, -8%-92%). Effectiveness was lowest in mothers with intrapartum fever (72%, 95% confidence interval, -9%-93%). On the basis of a 70% prevalence of maternal risk factors expected among cases in the absence of intrapartum antibiotic prophylaxis, we estimate that the risk-based strategy could reduce early-onset group B streptococcal disease by 60%. CONCLUSIONS: The risk-based approach to intrapartum antibiotic prophylaxis is effective in preventing early-onset group B streptococcal disease. To achieve the maximum preventive effect, the first dose of antibiotics should be administered at least 2 hours before delivery.

Original languageEnglish (US)
Pages (from-to)1204-1210
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume184
Issue number6
DOIs
StatePublished - Jan 1 2001

Fingerprint

Antibiotic Prophylaxis
Chemoprevention
Confidence Intervals
Mothers
Rupture
Fever
Anti-Bacterial Agents
Membranes
Premature Obstetric Labor
Contraception
Gestational Age
Medical Records

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Keywords

  • Early-onset disease
  • Effectiveness
  • Group B Streptococcus
  • Intrapartum antibiotic prophylaxis

Cite this

Lin, Feng Ying C. ; Brenner, Ruth A. ; Johnson, Yvette R. ; Azimi, Parvin H. ; Philips, Joseph B. ; Regan, Joan A. ; Clark, Penny ; Weisman, Leonard E. ; Rhoads, George ; Kong, Fanhui ; Clemens, John D. / The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. In: American Journal of Obstetrics and Gynecology. 2001 ; Vol. 184, No. 6. pp. 1204-1210.
@article{502013bbcf8b460faf1184a71704ccc6,
title = "The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease",
abstract = "OBJECTIVE: Our purpose was to evaluate the effectiveness of a risk-based intrapartum antibiotic prophylaxis strategy for the prevention of early-onset neonatal group B streptococcal disease. STUDY DESIGN: Cases and controls were selected from infants born to women with one or more risk factors: preterm labor or rupture of membranes, prolonged rupture of membranes (>18 hours), fever during labor, or previous child with group B streptococcal disease. Cases were matched with controls by birth hospital and gestational age. Data abstracted from medical records were analyzed to estimate the effectiveness of intrapartum antibiotic prophylaxis. RESULTS: We analyzed data from 109 cases and 207 controls. Nineteen (17{\%}) case versus 69 (33{\%}) control mothers received an acceptable regimen of intrapartum antibiotic prophylaxis. In adjusted analyses, the effectiveness of intrapartum antibiotic prophylaxis was 86{\%} (95{\%} confidence interval, 66{\%}-94{\%}). When the first dose of antibiotics was given ≥2 hours before delivery, the effectiveness increased to 89{\%} (95{\%} confidence interval, 70{\%}-96{\%}); when it was given within 2 hours of delivery, the effectiveness was 71{\%} (95{\%} confidence interval, -8{\%}-92{\%}). Effectiveness was lowest in mothers with intrapartum fever (72{\%}, 95{\%} confidence interval, -9{\%}-93{\%}). On the basis of a 70{\%} prevalence of maternal risk factors expected among cases in the absence of intrapartum antibiotic prophylaxis, we estimate that the risk-based strategy could reduce early-onset group B streptococcal disease by 60{\%}. CONCLUSIONS: The risk-based approach to intrapartum antibiotic prophylaxis is effective in preventing early-onset group B streptococcal disease. To achieve the maximum preventive effect, the first dose of antibiotics should be administered at least 2 hours before delivery.",
keywords = "Early-onset disease, Effectiveness, Group B Streptococcus, Intrapartum antibiotic prophylaxis",
author = "Lin, {Feng Ying C.} and Brenner, {Ruth A.} and Johnson, {Yvette R.} and Azimi, {Parvin H.} and Philips, {Joseph B.} and Regan, {Joan A.} and Penny Clark and Weisman, {Leonard E.} and George Rhoads and Fanhui Kong and Clemens, {John D.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1067/mob.2001.113875",
language = "English (US)",
volume = "184",
pages = "1204--1210",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

Lin, FYC, Brenner, RA, Johnson, YR, Azimi, PH, Philips, JB, Regan, JA, Clark, P, Weisman, LE, Rhoads, G, Kong, F & Clemens, JD 2001, 'The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease', American Journal of Obstetrics and Gynecology, vol. 184, no. 6, pp. 1204-1210. https://doi.org/10.1067/mob.2001.113875

The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. / Lin, Feng Ying C.; Brenner, Ruth A.; Johnson, Yvette R.; Azimi, Parvin H.; Philips, Joseph B.; Regan, Joan A.; Clark, Penny; Weisman, Leonard E.; Rhoads, George; Kong, Fanhui; Clemens, John D.

In: American Journal of Obstetrics and Gynecology, Vol. 184, No. 6, 01.01.2001, p. 1204-1210.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease

AU - Lin, Feng Ying C.

AU - Brenner, Ruth A.

AU - Johnson, Yvette R.

AU - Azimi, Parvin H.

AU - Philips, Joseph B.

AU - Regan, Joan A.

AU - Clark, Penny

AU - Weisman, Leonard E.

AU - Rhoads, George

AU - Kong, Fanhui

AU - Clemens, John D.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - OBJECTIVE: Our purpose was to evaluate the effectiveness of a risk-based intrapartum antibiotic prophylaxis strategy for the prevention of early-onset neonatal group B streptococcal disease. STUDY DESIGN: Cases and controls were selected from infants born to women with one or more risk factors: preterm labor or rupture of membranes, prolonged rupture of membranes (>18 hours), fever during labor, or previous child with group B streptococcal disease. Cases were matched with controls by birth hospital and gestational age. Data abstracted from medical records were analyzed to estimate the effectiveness of intrapartum antibiotic prophylaxis. RESULTS: We analyzed data from 109 cases and 207 controls. Nineteen (17%) case versus 69 (33%) control mothers received an acceptable regimen of intrapartum antibiotic prophylaxis. In adjusted analyses, the effectiveness of intrapartum antibiotic prophylaxis was 86% (95% confidence interval, 66%-94%). When the first dose of antibiotics was given ≥2 hours before delivery, the effectiveness increased to 89% (95% confidence interval, 70%-96%); when it was given within 2 hours of delivery, the effectiveness was 71% (95% confidence interval, -8%-92%). Effectiveness was lowest in mothers with intrapartum fever (72%, 95% confidence interval, -9%-93%). On the basis of a 70% prevalence of maternal risk factors expected among cases in the absence of intrapartum antibiotic prophylaxis, we estimate that the risk-based strategy could reduce early-onset group B streptococcal disease by 60%. CONCLUSIONS: The risk-based approach to intrapartum antibiotic prophylaxis is effective in preventing early-onset group B streptococcal disease. To achieve the maximum preventive effect, the first dose of antibiotics should be administered at least 2 hours before delivery.

AB - OBJECTIVE: Our purpose was to evaluate the effectiveness of a risk-based intrapartum antibiotic prophylaxis strategy for the prevention of early-onset neonatal group B streptococcal disease. STUDY DESIGN: Cases and controls were selected from infants born to women with one or more risk factors: preterm labor or rupture of membranes, prolonged rupture of membranes (>18 hours), fever during labor, or previous child with group B streptococcal disease. Cases were matched with controls by birth hospital and gestational age. Data abstracted from medical records were analyzed to estimate the effectiveness of intrapartum antibiotic prophylaxis. RESULTS: We analyzed data from 109 cases and 207 controls. Nineteen (17%) case versus 69 (33%) control mothers received an acceptable regimen of intrapartum antibiotic prophylaxis. In adjusted analyses, the effectiveness of intrapartum antibiotic prophylaxis was 86% (95% confidence interval, 66%-94%). When the first dose of antibiotics was given ≥2 hours before delivery, the effectiveness increased to 89% (95% confidence interval, 70%-96%); when it was given within 2 hours of delivery, the effectiveness was 71% (95% confidence interval, -8%-92%). Effectiveness was lowest in mothers with intrapartum fever (72%, 95% confidence interval, -9%-93%). On the basis of a 70% prevalence of maternal risk factors expected among cases in the absence of intrapartum antibiotic prophylaxis, we estimate that the risk-based strategy could reduce early-onset group B streptococcal disease by 60%. CONCLUSIONS: The risk-based approach to intrapartum antibiotic prophylaxis is effective in preventing early-onset group B streptococcal disease. To achieve the maximum preventive effect, the first dose of antibiotics should be administered at least 2 hours before delivery.

KW - Early-onset disease

KW - Effectiveness

KW - Group B Streptococcus

KW - Intrapartum antibiotic prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=0035340489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035340489&partnerID=8YFLogxK

U2 - 10.1067/mob.2001.113875

DO - 10.1067/mob.2001.113875

M3 - Article

C2 - 11349189

AN - SCOPUS:0035340489

VL - 184

SP - 1204

EP - 1210

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -